Haloperidol Tablets Clinical Trials

• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
  ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
  Affective Disorders
  
• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• Post-Operative Haloperidol Versus Placebo for Prevention of Post-Operative Delirium After Acute Hip Surgery.
  ClinicalTrials.gov Identifier: NCT00250237 - Recruiting
  Post-Operative Delirium; Hip Fracture
  
• A Comparison of Study Drug with Placebo and Haloperidol in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044044 - Active, not recruiting
  Schizophrenia
  
• A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
  ClinicalTrials.gov Identifier: NCT00457366 - Recruiting
  Agitation
  
• Maintenance Treatment Vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159120 - Active, not recruiting
  Schizophrenia; Psychoses
  
• Prodrome-Based Early Intervention with Antipsychotics Vs. Benzodiazepines in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159133 - Active, not recruiting
  Schizophrenia; Psychoses
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• Optimization of Acute Treatment in First Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00157378 - Active, not recruiting
  Schizophrenia, first-episode
  
• A Comparison of Dexmedetomidine and Haloperidol in Patients With ICU-Associated Agitation and Delirium
  ClinicalTrials.gov Identifier: NCT00505804 - Recruiting
  Delirium; Agitation; Ventilator Weaning; Respiration, Artificial; Intensive Care
  
• Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00395915 - Recruiting
  Schizophrenia
  
• Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00124930 - Recruiting
  Refractory Nausea
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
  ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
  Analgesia
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
  Parkinson Disease
  
• Pilot Study of Haloperidol to Treat Critical Illness Delirium
  ClinicalTrials.gov Identifier: NCT00429676 - Recruiting
  Delirium; Critical Illness
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
  Analgesics, Opioid.; Pain
  
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
  Chronic Hepatitis B
  
• A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
  Schizophrenia
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• Clozapine IM and Aggression in Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00189995 - Not yet recruiting
  Schizophrenia
  
• Lopinavir Capsules to Kaletra or Invirase Tablets
  ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
  HIV Infections
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00007774 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
  ClinicalTrials.gov Identifier: NCT00139854 - Completed
  Anxiety
  
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
  ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
  Allergy
  
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
  Allergy
  
• Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00018642 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
  ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
  Chronic Pain
  
• Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
  Malaria
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
  ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
  Menopause
  
• A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
  HIV Infection
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
  HIV Infection
  
• Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
  ClinicalTrials.gov Identifier: NCT00361166 - Completed
  Schizophrenia
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
  Menopause
  
• Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
  Pain; Cancer
  
• Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
  Pain; Cancer
  
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
  Posthepatitic Cirrhosis
  
• Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
  ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
  Smoking Cessation
  
• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
  Crohn''s Disease
  
• Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
  ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
  Pyuria; Urinary Tract Infections
  
• Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
  Myelodysplastic Syndrome (MDS)
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249119 - Completed
  Psychotic Disorder; Schizophrenia
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249132 - Completed
  Schizophrenia; Psychotic Disorders
  
• Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
  ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
  Urinary Tract Infection
  
• 5HT3 Antagonism and Auditory Gating in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00018850 - Completed
  Schizophrenia
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
  ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
  Parkinson's Disease
  
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
  ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
  Tobacco Dependence
  
• Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
  Rheumatoid Arthritis
  
• A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00139867 - Completed
  Parkinson''s Disease
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Open label trial exploring a switch from oral medications, to risperidone depot microspheres
  ClinicalTrials.gov Identifier: NCT00034775 - Completed
  Schizophrenia
  
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
  Restless Legs Syndrome
  
• Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00485901 - Completed
  Schizophrenia
  
• Agitation in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00000179 - Completed
  Alzheimer Disease
  
• The MIND Study: Modifying the INcidence of Delirium
  ClinicalTrials.gov Identifier: NCT00096863 - Completed
  Delirium; Cognition Disorders
  
• A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00253110 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Treatment of Behavioral Symptoms in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00009217 - Completed
  Alzheimer Disease
  
• Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
  ClinicalTrials.gov Identifier: NCT00035347 - Completed
  Pneumonia
  
• Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
  ClinicalTrials.gov Identifier: NCT00544024 - Completed
  Malaria
  
• Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
  ClinicalTrials.gov Identifier: NCT00062556 - Completed
  Intermittent Claudication; Peripheral Vascular Disease
  
• A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-Manic Effectiveness of Risperidone Compared With Haloperidol
  ClinicalTrials.gov Identifier: NCT00253162 - Completed
  Manic Disorder; Bipolar Disorders
  
• Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
  ClinicalTrials.gov Identifier: NCT00328718 - Completed
  Asthma
  
• Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00396799 - Completed
  Menopause
  
• Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
  ClinicalTrials.gov Identifier: NCT00167921 - Completed
  Atrophic Vaginitis
  
• A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
  ClinicalTrials.gov Identifier: NCT00500201 - Completed
  Schizophrenia
  
• Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
  ClinicalTrials.gov Identifier: NCT00550329 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
  
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00255528 - Completed
  Hypertension
  
• A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
  ClinicalTrials.gov Identifier: NCT00232154 - Completed
  Sinusitis
  
• Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
  ClinicalTrials.gov Identifier: NCT00203775 - Terminated
  Psychosis; Aggression
  
• An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
  ClinicalTrials.gov Identifier: NCT00344383 - Completed
  Metrorrhagia
  
• Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00169091 - Terminated
  Schizophrenia
  
• Micronutrients and Enteric Infections in African Children
  ClinicalTrials.gov Identifier: NCT00156832 - Completed
  Diarrhea
  
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
  ClinicalTrials.gov Identifier: NCT00000274 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
  ClinicalTrials.gov Identifier: NCT00195741 - Completed
  Migraine
  
• A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
  ClinicalTrials.gov Identifier: NCT00268827 - Completed
  HIV-1; AIDS
  
• Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00343629 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• A Study Comparing the Efficacy of Long-Acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00236457 - Completed
  Schizophrenia; Psychotic Disorders
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
  ClinicalTrials.gov Identifier: NCT00098189 - Completed
  Psoriasis
  
• Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
  ClinicalTrials.gov Identifier: NCT00387010 - Completed
  Pain
  
• A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
  ClinicalTrials.gov Identifier: NCT00225810 - Completed
  Crohn's Disease
  
• A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249223 - Completed
  Schizophrenia; Psychotic Disorders
  
• An Open-Label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-Dissolving Tablet Formulation of Risperdone
  ClinicalTrials.gov Identifier: NCT00246272 - Completed
  Schizophrenia
  
• Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00195767 - Completed
  Bipolar I Disorder, Manic or Mixed
  
• Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00483652 - Completed
  Multiple Sclerosis